Latest filing published 21 May 2026 for Phathom Pharmaceuticals, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Heidi Fields (board member) discloses dealings in 4 companies, chiefly Agilent Technologies, Inc., Phathom Pharmaceuticals, Inc. and Icosavax, Inc. Between 4 January 2016 and 19 May 2026, the trades on record add up to 14 filings.
No open-market purchase appears, only 2 sales worth €770k. Besides market trades, the filings include 11 share grants.
The latest filing, published on 21 May 2026, reports a share grant in Phathom Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations